Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2026)

Collegium Pharmaceutical's Other Operating Expenses history runs 7 years deep, the most recent figure standing at -$463000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 96.95% year-over-year to -$463000.0; the TTM figure through Mar 2026 stood at -$21.6 million (up 68.91% YoY), while the FY2025 annual figure was -$5.4 million, up 66.05% from the prior year.
• Other Operating Expenses was -$463000.0 for Q1 2026 at Collegium Pharmaceutical, down from -$19000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $11.6 million in Q3 2023 to a low of -$207.0 million in Q4 2023.
• Historically, Other Operating Expenses has averaged -$26.8 million across 4 years, with a median of -$8.6 million in 2024.
• Biggest YoY gain for Other Operating Expenses was 99.96% in 2025; the steepest drop was 302.67% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at -$207.0 million in 2023, then surged by 74.99% to -$51.8 million in 2024, then soared by 99.96% to -$19000.0 in 2025, then slumped by 2336.84% to -$463000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$463000.0 (Q1 2026), -$19000.0 (Q4 2025), and -$10.9 million (Q3 2025), per Business Quant data.